Maypharm launches hyaluronic acid body filler

Maypharm has launched SEDY FILL, a hyaluronic acid body filler, and an injectable dermal filler designed for non-surgical correction of body shape. Its product composition uniquely lies in the presence of cross-linked hyaluronic acid produced by innovative HENM technology.

A wide range of hyaluronic acid body fillers exist in the market, giving doctors and patients the ability to fully customise according to need or preference.

SEDY FILL has been improved over time to enhance the breasts and buttocks, even with implants, fat grafting, and other injectable fillers. It is now being sold to more than 30 countries across the globe and is consistently chosen as the best option to enhance beauty.

According to Maypharm, this product features strong viscosity and cohesiveness for resistance to migration; optimal gel strength that can be adjusted according to the patient's needs; malleability that makes it easier to handle and mold during the procedure. As such the product is intended for the correction of breast shape and size, replenishment of buttock volume, and leg asymmetry correction.

The patented HA technology is the only technology that allows SEDY FILL to turn into a semi-solid state gel. This provides long-lasting effectiveness and improved product safety since a pure HA gel that is produced can be easily removed as needed without any residue. A single application of of the product remains effective for 12-15 months on average and up to 2 years with delicate care.

SEDY  FILL can be completely removed with a hyaluronidase injection. While it can withstand the naturally occurring hyaluronidase in the body for a long-lasting effect, any gel remaining in the soft tissue may easily be dissolved by injecting hyaluronidase directly into the desired area. The product retains 100% of the cross-linked HA and is a highly hydrophilic product with a stable particle structure.